Citadel Advisors »

Edgewise Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Edgewise Therapeutics (EWTX) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Edgewise Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Edgewise Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Edgewise Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $50M 2.7M 18.24
2023-12-31 $28M 2.6M 10.94
2023-09-30 $16M 2.8M 5.73
2023-06-30 $21M 2.7M 7.75
2023-03-31 $19M 2.8M 6.67
2022-12-31 $26M 2.9M 8.94
2022-06-30 $20M 2.5M 7.96
2022-03-31 $26M 2.6M 9.70
2021-12-31 $38M 2.5M 15.28
2021-09-30 $40M 2.4M 16.60
2021-06-30 $53M 2.5M 21.33
2021-03-31 $74M 2.4M 31.06